Hub : Traits

Short access day 10 total locomotion

Tags: Behavior · Cocaine · Short access

Project: p50_paul_meyer_2020

6 loci · 6 genes with independent associations · 7 total associated genes

Significant Loci

#	Chr	Start pos	End pos	# assoc genes	# joint models	Best TWAS P	Best GWAS P	Cond GWAS P	Joint genes
1	chr2	28917267	30316015	1	1	1.87e-08	3.11e-04	5.63e-01	Polk
2	chr2	144511896	145907690	1	1	1.57e-15	4.49e-01	6.27e-18	Mindy4b
3	chr8	41432021	42517271	1	1	4.36e-17	1.67e-01	2.28e-05	Foxred1
4	chr9	83390749	84777604	2	1	0.00e+00	7.18e-02	1.00e+00	Retreg2
5	chr13	84702566	86100919	1	1	1.83e-08	5.76e-02	2.28e-06	Olfml2b
6	chr17	61510864	62906219	1	1	5.06e-11	6.03e-02	4.52e-02	Ccny

Pleiotropic Associations

Trait	Chi2 ratio	# genes+	# genes++	% genes++	Corr	Corr P	Genes
BMI with tail	964.34	4	2	33.3	-1	4.08e-03	Foxred1 Mindy4b Olfml2b Retreg2
BMI without tail	28811.1	4	2	33.3	1	6.34e-06	Ccny Mindy4b Olfml2b Retreg2
Body weight	4.58	3	1	16.7	0	1.00e+00	Mindy4b Olfml2b Retreg2
Epididymis fat weight	36173.48	2	2	33.3	0	1.00e+00	Ccny Retreg2
Glucose	2366.35	1	1	16.7	0	1.00e+00	Retreg2
Heart weight	6763.89	2	2	33.3	0	1.00e+00	Ccny Retreg2
Left kidney weight	23546.57	5	1	16.7	-1	6.49e-08	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Right kidney weight	29218.45	3	2	33.3	-1	1.45e-04	Ccny Foxred1 Retreg2
Tail length	30717.51	2	2	33.3	0	1.00e+00	Ccny Retreg2
Length with tail	2048.48	2	1	16.7	0	1.00e+00	Foxred1 Retreg2
Length without tail	32336.71	3	2	33.3	-1	3.90e-04	Ccny Mindy4b Retreg2
Liver weight, left	7265.45	2	2	33.3	0	1.00e+00	Ccny Retreg2
Liver weight, right	129.69	2	1	16.7	0	1.00e+00	Ccny Retreg2
Parametrial fat weight	209.08	3	1	16.7	0	1.00e+00	Ccny Foxred1 Retreg2
Retroperitoneal fat weight	5355.25	2	1	16.7	0	1.00e+00	Mindy4b Retreg2
Intraocular pressure	20040.92	1	1	16.7	0	1.00e+00	Retreg2
Extensor digitorum longus weight	2342.73	2	1	16.7	0	1.00e+00	Mindy4b Retreg2
Soleus weight	41.43	3	1	16.7	0	1.00e+00	Ccny Olfml2b Retreg2
Tibialis anterior weight	2442.27	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Tibia length	3259.43	1	1	16.7	0	1.00e+00	Retreg2
Number of licking bursts	52378.83	2	1	16.7	0	1.00e+00	Ccny Retreg2
Food consumed during 24 hour testing period	35405.76	2	1	16.7	0	1.00e+00	Ccny Retreg2
Times rat made contact with spout	305.36	1	1	16.7	0	1.00e+00	Retreg2
Mean time between licks in bursts	66505.9	2	1	16.7	0	1.00e+00	Ccny Retreg2
Mean num. licks in bursts	47539.71	2	1	16.7	0	1.00e+00	Ccny Retreg2
Std. dev. time between licks in bursts	47023.26	1	1	16.7	0	1.00e+00	Retreg2
Water consumed over 24 hours	34477.35	2	1	16.7	0	1.00e+00	Ccny Retreg2
Patch foraging indifference point 0 sec	115003.89	1	1	16.7	0	1.00e+00	Retreg2
Patch foraging indifference point AUC	44400.63	2	2	33.3	0	1.00e+00	Ccny Retreg2
Indifference point function ln k	35522.91	3	2	33.3	1	8.27e-05	Ccny Olfml2b Retreg2
Indifference point function log k	35522.91	3	2	33.3	1	8.27e-05	Ccny Olfml2b Retreg2
Patch foraging total patch changes 0 sec	60133.55	1	1	16.7	0	1.00e+00	Retreg2
Patch foraging total patch changes 12 sec	3670.27	3	2	33.3	0	1.00e+00	Ccny Foxred1 Retreg2
Patch foraging total patch changes 18 sec	39260.23	2	1	16.7	0	1.00e+00	Ccny Retreg2
Patch foraging total patch changes 24 sec	55706.51	2	2	33.3	0	1.00e+00	Ccny Retreg2
Patch foraging total patch changes 6 sec	10903.24	3	2	33.3	0	1.00e+00	Ccny Mindy4b Retreg2
Patch foraging time to switch 0 sec	52212.82	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Patch foraging water rate 0 sec	49607.45	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Patch foraging water rate 12 sec	40481.51	3	2	33.3	-1	1.41e-04	Ccny Polk Retreg2
Patch foraging water rate 18 sec	34430.86	2	1	16.7	0	1.00e+00	Ccny Retreg2
Patch foraging water rate 24 sec	2357.13	2	2	33.3	0	1.00e+00	Ccny Retreg2
Patch foraging water rate 6 sec	1356.15	3	2	33.3	0	1.00e+00	Ccny Polk Retreg2
Locomotor activity	26.33	3	1	16.7	0	1.00e+00	Ccny Foxred1 Retreg2
Locomotor testing distance	17917.43	4	2	33.3	-1	1.01e-05	Ccny Foxred1 Polk Retreg2
Locomotor testing rearing	50814.92	2	1	16.7	0	1.00e+00	Foxred1 Retreg2
Light reinforcement 1	31072.44	4	2	33.3	-1	2.20e-05	Ccny Mindy4b Polk Retreg2
Light reinforcement 2	27014.42	3	2	33.3	-1	1.21e-03	Ccny Mindy4b Retreg2
Reaction time number correct	30703.4	4	2	33.3	-1	9.48e-06	Ccny Olfml2b Polk Retreg2
Reaction time mean minus median	51458.61	3	1	16.7	1	6.61e-05	Ccny Olfml2b Retreg2
Reaction time mean minus median AUC	69472.79	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Reaction time num false alarms	28557.11	2	2	33.3	0	1.00e+00	Ccny Retreg2
Reaction time num false alarms AUC	35512.89	2	2	33.3	0	1.00e+00	Ccny Retreg2
Reaction time trials correct on left	30703.4	4	2	33.3	-1	9.48e-06	Ccny Olfml2b Polk Retreg2
Reaction time trials on left	30010.62	4	2	33.3	-1	1.15e-05	Ccny Olfml2b Polk Retreg2
Reaction time mean	23605.29	3	2	33.3	1	6.06e-06	Ccny Mindy4b Retreg2
Reaction time mean AUC	28345.36	3	2	33.3	1	3.38e-06	Ccny Mindy4b Retreg2
Median of all reaction times	10486.95	2	2	33.3	0	1.00e+00	Mindy4b Retreg2
Reaction time omissions	11428.95	2	1	16.7	0	1.00e+00	Mindy4b Retreg2
Reaction time false alarm rate	891.26	1	1	16.7	0	1.00e+00	Retreg2
Reaction time premature initiation rate	9225.42	4	1	16.7	-1	7.70e-05	Ccny Mindy4b Polk Retreg2
Reaction time premature initiations	34684.95	3	1	16.7	-1	1.26e-04	Ccny Mindy4b Retreg2
Std. dev. reaction times	37378.13	3	1	16.7	1	4.78e-05	Mindy4b Olfml2b Retreg2
Reaction time trials completed	30010.62	4	2	33.3	-1	1.15e-05	Ccny Olfml2b Polk Retreg2
Reaction time trials AUC	30351.8	4	2	33.3	-1	1.16e-05	Ccny Olfml2b Polk Retreg2
Social response proportion	17656.04	2	1	16.7	0	1.00e+00	Mindy4b Retreg2
Social responses	2856.43	2	2	33.3	0	1.00e+00	Ccny Retreg2
Social time	22121.54	2	1	16.7	0	1.00e+00	Ccny Retreg2
Conditioned locomotion	3044.63	2	1	16.7	0	1.00e+00	Ccny Retreg2
Cocaine response after cond. corrected	21948.64	2	1	16.7	0	1.00e+00	Ccny Retreg2
Cocaine response after cond. not corrected	21423.84	2	1	16.7	0	1.00e+00	Ccny Retreg2
Cocaine response before conditioning	1409.02	2	1	16.7	0	1.00e+00	Ccny Retreg2
Saline control response	6484.47	1	1	16.7	0	1.00e+00	Retreg2
Condit. Reinf. active minus inactive responses	53410.48	1	1	16.7	0	1.00e+00	Retreg2
Condit. Reinf. active-inactive response ratio	91582.24	1	1	16.7	0	1.00e+00	Retreg2
Condit. Reinf. active responses	9691.24	1	1	16.7	0	1.00e+00	Retreg2
Condit. Reinf. inactive responses	21056.03	2	1	16.7	0	1.00e+00	Ccny Retreg2
Condit. Reinf. lever presses	15873.43	1	1	16.7	0	1.00e+00	Retreg2
Condit. Reinf. lever reinforcers received	2000.77	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. lever latency	10912.53	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. magazine entry latency	24714.14	2	1	16.7	0	1.00e+00	Ccny Retreg2
Pavlov. Cond. change in total contacts	57394.24	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. index score	23998.4	2	1	16.7	0	1.00e+00	Ccny Retreg2
Pavlov. Cond. latency score	29242.48	2	1	16.7	0	1.00e+00	Ccny Retreg2
Pavlov. Cond. lever contacts	22069.78	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. magazine entry number	16773.11	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. intertrial magazine entries	52471.02	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. lever-magazine prob. diff.	22438.69	2	1	16.7	0	1.00e+00	Ccny Retreg2
Pavlov. Cond. response bias	5169.79	1	1	16.7	0	1.00e+00	Retreg2
Conditioned reinforcement - actives	47880.88	3	2	33.3	1	9.51e-07	Ccny Olfml2b Retreg2
Conditioned reinforcement - inactives	31015.56	4	2	33.3	1	2.51e-06	Ccny Foxred1 Olfml2b Retreg2
Conditioned locomotion	8301.6	5	3	50	1	6.74e-05	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Intermittent access intake day 1-15 change	35107.77	5	3	50	1	2.50e-07	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Intermittent access intake escalation	41918.88	4	2	33.3	1	1.08e-05	Foxred1 Mindy4b Olfml2b Retreg2
Intermittent access intake escalation 2	27046.04	4	3	50	1	1.21e-03	Ccny Foxred1 Olfml2b Retreg2
Intermitt. access day 1 inactive lever presses	47312.73	4	1	16.7	1	8.71e-07	Ccny Olfml2b Polk Retreg2
Intermitt. access day 15 inactive lever presses	41657.43	4	3	50	1	2.17e-06	Foxred1 Olfml2b Polk Retreg2
Intermitt. access escalation Index	37005.67	4	1	16.7	-1	1.61e-06	Ccny Mindy4b Olfml2b Retreg2
Intermittent access day 1 total infusions	25926.65	5	1	16.7	-1	3.05e-07	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Intermittent access day 15 total infusions	26309.76	4	3	50	1	6.57e-06	Ccny Foxred1 Olfml2b Retreg2
Intermittent access terminal intake (last 3 days)	20815.71	4	3	50	1	1.70e-04	Ccny Foxred1 Olfml2b Retreg2
Intermittent access total infusions	180.6	4	1	16.7	-0.96	4.45e-02	Ccny Foxred1 Olfml2b Retreg2
Intermittent access day 1 locomotion	17422.54	5	3	50	-1	4.35e-07	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Intermittent access day 15 total locomotion	44477.18	3	2	33.3	1	3.57e-04	Ccny Olfml2b Retreg2
Intermittent access total locomotion	244.39	3	1	16.7	0	1.00e+00	Mindy4b Olfml2b Retreg2
Intermittent access standard deviation	40395.87	4	2	33.3	1	2.41e-06	Ccny Foxred1 Olfml2b Retreg2
Cocaine induced anxiety	32065.94	4	2	33.3	-1	1.81e-06	Ccny Foxred1 Polk Retreg2
Post-drug Anxiety	6826.9	2	1	16.7	0	1.00e+00	Polk Retreg2
Baseline Anxiety	25888.27	3	2	33.3	1	4.76e-04	Ccny Foxred1 Retreg2
Lifetime Intake	1724.53	4	2	33.3	-0.99	7.23e-03	Ccny Foxred1 Olfml2b Retreg2
Incentive Sensitization - Responses	32726.16	4	2	33.3	-1	1.12e-05	Ccny Mindy4b Olfml2b Retreg2
Incentive Sensitization - Breakpoint	23808.41	5	2	33.3	-1	4.26e-07	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Progressive ratio test 1 active lever presses	24987.24	3	2	33.3	1	1.40e-04	Ccny Olfml2b Retreg2
Progressive ratio test 1 breakpoint	24079.48	3	2	33.3	1	1.27e-04	Ccny Olfml2b Retreg2
Progressive ratio test 1 inactive lever presses	30226.96	4	2	33.3	1	1.60e-06	Ccny Foxred1 Polk Retreg2
Progressive ratio test 2 active lever presses	11457.86	4	2	33.3	-1	5.05e-05	Ccny Mindy4b Olfml2b Retreg2
Progressive ratio test 2 breakpoint	7012.68	4	2	33.3	-1	1.28e-04	Ccny Mindy4b Olfml2b Retreg2
Progressive ratio test 2 inactive lever presses	41035.17	3	2	33.3	1	1.31e-04	Ccny Foxred1 Retreg2
Total sessions with >9 infusions	2017.68	4	2	33.3	-0.99	1.15e-02	Ccny Mindy4b Olfml2b Retreg2
Short access day 1 total inactive lever presses	22887.76	4	2	33.3	-1	3.31e-06	Ccny Foxred1 Mindy4b Retreg2
Short access day 10 total inactive lever presses	54317.8	3	2	33.3	1	7.95e-05	Ccny Olfml2b Retreg2
Short access day 1 total infusions	27935.77	3	2	33.3	-1	1.28e-03	Ccny Foxred1 Retreg2
Short access day 10 total infusions	15265.02	4	1	16.7	-1	1.61e-05	Ccny Olfml2b Polk Retreg2
Short access total infusions	11354.14	3	2	33.3	0	1.00e+00	Ccny Mindy4b Retreg2
Short access day 1 locomotion	16827.03	4	2	33.3	1	1.75e-06	Ccny Foxred1 Polk Retreg2
Short access total locomotion	11389.47	5	2	33.3	1	2.07e-08	Foxred1 Mindy4b Olfml2b Polk Retreg2
Compulsive drug intake	13096.51	4	2	33.3	-1	1.64e-06	Ccny Foxred1 Mindy4b Retreg2
One hour access (0.3 mA shock)	2447.71	4	3	50	0.99	7.50e-03	Ccny Foxred1 Mindy4b Retreg2
One hour access (shock baseline)	35072.97	3	1	16.7	1	1.37e-04	Ccny Foxred1 Retreg2
Number of responses in last shaping day	8574.61	5	2	33.3	1	7.35e-06	Ccny Foxred1 Mindy4b Polk Retreg2
Context. condit. distance diff. score	970.59	1	1	16.7	0	1.00e+00	Retreg2
Locomotion velocity, session 1	14615.25	1	1	16.7	0	1.00e+00	Retreg2
Locomotion distance, session 1	2213.01	2	1	16.7	0	1.00e+00	Ccny Retreg2
Locomotion velocity, session 2	9358	1	1	16.7	0	1.00e+00	Retreg2
Locomotion distance, session 2	1206.44	2	1	16.7	0	1.00e+00	Ccny Retreg2
Locomotion velocity, session 3	2332.53	1	1	16.7	0	1.00e+00	Retreg2
Locomotion distance, session 3	16615.78	1	1	16.7	0	1.00e+00	Retreg2
Stereotopy head waving bouts, day 3	5866.4	1	1	16.7	0	1.00e+00	Retreg2
Stereotopy head waving duration, day 3	12131.92	1	1	16.7	0	1.00e+00	Retreg2
Locomotion velocity, session 7	1310.17	1	1	16.7	0	1.00e+00	Retreg2
Locomotion distance, session 7	3744.54	1	1	16.7	0	1.00e+00	Retreg2
Stereotopy head waving bouts, day 7	10466.92	1	1	16.7	0	1.00e+00	Retreg2
Stereotopy head waving duration, day 7	8847.36	1	1	16.7	0	1.00e+00	Retreg2
Locomotion velocity, session 8	950.4	2	1	16.7	0	1.00e+00	Ccny Retreg2
Locomotion distance, session 8	673.32	1	1	16.7	0	1.00e+00	Retreg2
Degree of sensitization distance	15309.16	1	1	16.7	0	1.00e+00	Retreg2
Degree of sensitization stereotypy	8496.38	1	1	16.7	0	1.00e+00	Retreg2
Condit. Reinf. active minus inactive responses	1380.95	3	1	16.7	0	1.00e+00	Ccny Mindy4b Retreg2
Condit. Reinf. active-inactive response ratio	553.67	2	1	16.7	0	1.00e+00	Mindy4b Retreg2
Condit. Reinf. active responses	3895.25	3	1	16.7	0	1.00e+00	Ccny Mindy4b Retreg2
Condit. Reinf. inactive responses	19375.3	1	1	16.7	0	1.00e+00	Retreg2
Incentive salience index mean	7397.37	2	1	16.7	0	1.00e+00	Ccny Retreg2
Condit. Reinf. lever presses	21433.81	1	1	16.7	0	1.00e+00	Retreg2
Time in familiar zone, hab. session 1	20942.04	1	1	16.7	0	1.00e+00	Retreg2
Time in novel zone, hab. session 1	17764.8	1	1	16.7	0	1.00e+00	Retreg2
Total zone transitions, hab. session 1	1818.53	1	1	16.7	0	1.00e+00	Retreg2
Total locomotion distance, hab. session 1	849.35	2	1	16.7	0	1.00e+00	Ccny Retreg2
Locomotion velocity, hab. session 1	571.33	2	1	16.7	0	1.00e+00	Ccny Retreg2
Time in familiar zone, hab. session 2	11692.92	1	1	16.7	0	1.00e+00	Retreg2
Time in novel zone, hab. session 2	12466.52	1	1	16.7	0	1.00e+00	Retreg2
Total zone transitions, hab. session 2	280.53	1	1	16.7	0	1.00e+00	Retreg2
Total locomotion distance, hab. session 2	51.92	2	1	16.7	0	1.00e+00	Ccny Retreg2
Locomotion velocity, hab. session 2	77.91	2	1	16.7	0	1.00e+00	Ccny Retreg2
Novel to familiar place preference ratio	18508.59	2	1	16.7	0	1.00e+00	Ccny Retreg2
Novelty place preference	27195.73	2	1	16.7	0	1.00e+00	Ccny Retreg2
Time in novel zone, NPP test	40844.77	1	1	16.7	0	1.00e+00	Retreg2
Total zone transitions, NPP test	8230.03	1	1	16.7	0	1.00e+00	Retreg2
Total locomotion distance, NPP test	3566.83	2	2	33.3	0	1.00e+00	Ccny Retreg2
Locomotion velocity, NPP test	2031.76	2	2	33.3	0	1.00e+00	Ccny Retreg2
Pavlov. Cond. lever latency	2195.61	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. magazine entry latency	8.04	1	0	0	0	1.00e+00	Ccny
Pavlov. Cond. change in total contacts	2273.55	2	1	16.7	0	1.00e+00	Ccny Retreg2
Pavlov. Cond. index score	1769.33	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. latency score	1841.19	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. lever contacts	3029.77	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. magazine entry number	1086.53	2	1	16.7	0	1.00e+00	Ccny Retreg2
Pavlov. Cond. intertrial magazine entries	266.85	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Pavlov. Cond. lever-magazine prob. diff.	1940.27	1	1	16.7	0	1.00e+00	Retreg2
Pavlov. Cond. response bias	2606.99	1	1	16.7	0	1.00e+00	Retreg2
Bone: apparent density	22268.03	1	1	16.7	0	1.00e+00	Retreg2
Bone surface	25125.6	1	1	16.7	0	1.00e+00	Retreg2
Bone volume	33831.7	1	1	16.7	0	1.00e+00	Retreg2
Bone: connectivity density	7098.55	1	1	16.7	0	1.00e+00	Retreg2
Bone: cortical apparent density	22635.68	2	1	16.7	0	1.00e+00	Ccny Retreg2
Bone: cortical area	18930.98	1	1	16.7	0	1.00e+00	Retreg2
Bone: cortical porosity	1837.29	1	1	16.7	0	1.00e+00	Retreg2
Bone: cortical porosity	4807.78	1	1	16.7	0	1.00e+00	Retreg2
Bone: cortical thickness	1627.26	1	1	16.7	0	1.00e+00	Retreg2
Bone: cortical thickness	12190.6	1	1	16.7	0	1.00e+00	Retreg2
Bone: cortical tissue density	24229.43	2	1	16.7	0	1.00e+00	Ccny Retreg2
Bone: elastic displacement	14817.48	1	1	16.7	0	1.00e+00	Retreg2
Bone: elastic work	1494.59	1	1	16.7	0	1.00e+00	Retreg2
Bone: endosteal estimation	35257.61	1	1	16.7	0	1.00e+00	Retreg2
Bone: endosteal perimeter	22350.62	1	1	16.7	0	1.00e+00	Retreg2
Bone: final force	7031.22	1	1	16.7	0	1.00e+00	Retreg2
Bone: final moment	1042.62	1	1	16.7	0	1.00e+00	Retreg2
Bone: marrow area	37067.95	1	1	16.7	0	1.00e+00	Retreg2
Bone: maximum diameter	24401.62	1	1	16.7	0	1.00e+00	Retreg2
Bone: maximum force	34553.99	1	1	16.7	0	1.00e+00	Retreg2
Bone: maximum moment	24715.64	1	1	16.7	0	1.00e+00	Retreg2
Bone: minimum diameter	17196.64	1	1	16.7	0	1.00e+00	Retreg2
Bone: periosteal estimation	38190.5	1	1	16.7	0	1.00e+00	Retreg2
Bone: periosteal perimeter	43183.28	1	1	16.7	0	1.00e+00	Retreg2
Bone: post-yield work	25426.03	2	1	16.7	0	1.00e+00	Mindy4b Retreg2
Bone: stiffness	35564.91	1	1	16.7	0	1.00e+00	Retreg2
Bone: tissue strength	12264.67	1	1	16.7	0	1.00e+00	Retreg2
Bone: trabecular number	41138.39	1	1	16.7	0	1.00e+00	Retreg2
Bone: trabecular spacing	31287.85	1	1	16.7	0	1.00e+00	Retreg2
Bone: trabecular thickness	33264.33	1	1	16.7	0	1.00e+00	Retreg2
Bone: trabecular tissue density	26819.29	2	2	33.3	0	1.00e+00	Ccny Retreg2
Breakpoint value in progressive ratio session	37484.23	2	1	16.7	0	1.00e+00	Ccny Retreg2
Distance traveled before self-admin	33524.56	3	2	33.3	1	3.74e-04	Ccny Foxred1 Retreg2
Distance traveled after self-admin	33650.45	3	2	33.3	0	1.00e+00	Ccny Foxred1 Retreg2
Delta time in closed arm before/after self-admin	696.27	3	2	33.3	0	1.00e+00	Ccny Foxred1 Retreg2
Delta time in open arm before/after self-admin	13726.5	3	2	33.3	1	5.31e-04	Ccny Olfml2b Retreg2
Diff in mean of infusions in LGA sessions	36171.12	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Extinction: sum of active levers before priming	18357.7	4	3	50	1	4.98e-05	Ccny Foxred1 Mindy4b Retreg2
Active lever presses in extinction session 6	1120.26	3	2	33.3	0	1.00e+00	Ccny Foxred1 Retreg2
Delta distance traveled before/after self-admin	3150.59	3	2	33.3	-0.99	5.85e-03	Ccny Foxred1 Retreg2
Delta ambulatory time before/after self-admin	24034.38	3	2	33.3	-1	4.94e-04	Ccny Foxred1 Retreg2
Time in closed arm before self-admin	22073.91	3	2	33.3	-1	3.83e-04	Ccny Foxred1 Retreg2
Time in closed arm after self-admin	9901.19	2	2	33.3	0	1.00e+00	Ccny Retreg2
Time in open arm before self-admin	11580.26	2	2	33.3	0	1.00e+00	Ccny Retreg2
Time in open arm after self-admin	657.22	3	2	33.3	0	1.00e+00	Ccny Foxred1 Retreg2
Sum of active levers in priming session hrs 5-6	1947.63	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Time to tail flick, vehicle, before self-admin	12969.27	3	2	33.3	1	4.02e-03	Ccny Foxred1 Retreg2
Time to tail flick, vehicle, after self-admin	23670.72	4	2	33.3	1	3.57e-06	Ccny Foxred1 Mindy4b Retreg2
Time to tail flick, test, before self-admin	10943.57	3	1	16.7	0	1.00e+00	Ccny Foxred1 Retreg2
Time to tail flick, test, after self-admin	1506.9	4	3	50	0.99	5.25e-03	Ccny Foxred1 Mindy4b Retreg2
Delta time to tail flick, vehicle, before/after SA	9230.61	3	2	33.3	1	4.68e-03	Ccny Mindy4b Retreg2
Delta time to tail flick, test, before/after SA	18955.66	3	1	16.7	0	1.00e+00	Ccny Mindy4b Retreg2
Ambulatory time before self-admin	42793.65	3	3	50	1	3.20e-04	Ccny Foxred1 Retreg2
Ambulatory time after self-admin	44153.3	2	2	33.3	0	1.00e+00	Ccny Retreg2
Total heroin consumption	282.44	4	3	50	0.93	6.89e-02	Ccny Foxred1 Olfml2b Retreg2
Area under the delay curve	16330.12	4	1	16.7	-1	3.58e-06	Ccny Mindy4b Olfml2b Retreg2
Delay disc. indifference point, 0s delay	3166.23	3	1	16.7	0	1.00e+00	Mindy4b Olfml2b Retreg2
Delay disc. indifference point, 16s delay	14978.96	4	2	33.3	-1	6.93e-06	Ccny Mindy4b Olfml2b Retreg2
Delay disc. indifference point, 2s delay	280.85	3	1	16.7	0	1.00e+00	Ccny Mindy4b Retreg2
Delay disc. indifference point, 24s delay	25016.33	3	2	33.3	-1	1.68e-04	Ccny Olfml2b Retreg2
Delay disc. indifference point, 4s delay	657.32	4	2	33.3	-0.98	2.04e-02	Ccny Mindy4b Olfml2b Retreg2
Delay disc. indifference point, 8s delay	50718.73	1	1	16.7	0	1.00e+00	Retreg2
Delay discount exponential model param	15060.97	3	1	16.7	1	2.88e-04	Mindy4b Olfml2b Retreg2
Delay discount hyperbolic model param	11437.69	3	1	16.7	1	4.78e-04	Mindy4b Olfml2b Retreg2
Fecal boli incidents, locomotor time 1	37546.95	3	1	16.7	-1	2.79e-04	Ccny Olfml2b Retreg2
Change in fecal boli incidents, locomotor task	7884.69	3	2	33.3	0	1.00e+00	Ccny Mindy4b Retreg2
Time >=10cm from walls, locomotor time 1	9869.48	4	2	33.3	-1	1.69e-05	Ccny Mindy4b Olfml2b Retreg2
Bouts of movement, locomotor time 1	13897.76	3	2	33.3	0	1.00e+00	Ccny Polk Retreg2
Total resting periods, locomotor time 1	3962.64	3	2	33.3	0	1.00e+00	Ccny Polk Retreg2
Rest time, locomotor task time 1	25324.16	2	1	16.7	0	1.00e+00	Ccny Retreg2
Distance moved, locomotor task time 1	39829.98	3	2	33.3	-1	1.29e-04	Ccny Polk Retreg2
Vertical activity count, locomotor time 1	73027.65	2	1	16.7	0	1.00e+00	Polk Retreg2
Time >=10cm from walls, locomotor time 2	32403.71	4	2	33.3	1	6.68e-06	Ccny Mindy4b Olfml2b Retreg2
Bouts of movement, locomotor time 2	29059.24	5	2	33.3	1	1.06e-07	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Total resting periods, locomotor time 2	31687.74	5	2	33.3	1	6.74e-08	Ccny Foxred1 Mindy4b Olfml2b Retreg2
Rest time, locomotor task time 2	20953.67	3	2	33.3	-1	7.11e-05	Ccny Olfml2b Retreg2
Distance moved, locomotor task time 2	11481.69	3	2	33.3	0	1.00e+00	Ccny Mindy4b Retreg2
Vertical activity count, locomotor time 2	34624	3	3	50	-1	3.99e-04	Ccny Mindy4b Retreg2
Weight adjusted by age	54020.54	2	2	33.3	0	1.00e+00	Ccny Retreg2
Seeking ratio, delayed vs. immediate footshock	16476.76	3	2	33.3	0	1.00e+00	Ccny Mindy4b Retreg2
Locomotion in novel chamber	5443.91	3	2	33.3	0	1.00e+00	Ccny Olfml2b Retreg2
Locomotion in novel chamber post-restriction	38665.29	3	1	16.7	-1	1.45e-04	Ccny Mindy4b Retreg2
Progressive ratio	52652.41	2	2	33.3	0	1.00e+00	Ccny Retreg2
Food seeking constrained by brief footshock	7338.76	1	1	16.7	0	1.00e+00	Retreg2
Seeking ratio, punishment vs. effort	39433.67	2	2	33.3	0	1.00e+00	Ccny Retreg2
Run reversals in cocaine runway, females	9305.82	4	1	16.7	-1	3.08e-04	Ccny Foxred1 Olfml2b Retreg2
Run reversals in cocaine runway, males	7476.43	3	1	16.7	1	8.57e-04	Ccny Foxred1 Retreg2
Latency to leave start box in cocaine runway	19548.1	3	2	33.3	0	1.00e+00	Ccny Olfml2b Retreg2
Latency to leave start box in cocaine runway, F	9464.89	3	1	16.7	0	1.00e+00	Mindy4b Olfml2b Retreg2
Latency to leave start box in cocaine runway, M	2453.48	3	2	33.3	0	1.00e+00	Ccny Foxred1 Retreg2
Co content in liver	4721.74	1	1	16.7	0	1.00e+00	Retreg2
Cu content in liver	162.43	1	1	16.7	0	1.00e+00	Retreg2
Fe content in liver	5656.2	1	1	16.7	0	1.00e+00	Retreg2
K content in liver	6593.53	1	1	16.7	0	1.00e+00	Retreg2
Mg content in liver	12254.82	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Mn content in liver	2193.4	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Na content in liver	8324.6	2	1	16.7	0	1.00e+00	Olfml2b Retreg2
Rb content in liver	428.45	1	1	16.7	0	1.00e+00	Retreg2
Se content in liver	7.21	1	0	0	0	1.00e+00	Olfml2b
Zn content in liver	15755.62	1	1	16.7	0	1.00e+00	Retreg2

Associations by panel

Tissue	RNA modality	# hits	% hits/tests	Avg chisq
Adipose	alternative polyA	0	0	1.11
Adipose	alternative TSS	0	0	1.18
Adipose	gene expression	0	0	1.21
Adipose	isoform ratio	0	0	1.14
Adipose	intron excision ratio	0	0	1.2
Adipose	mRNA stability	0	0	1.22
BLA	alternative polyA	0	0	1.12
BLA	alternative TSS	0	0	1.24
BLA	gene expression	0	0	1.26
BLA	isoform ratio	0	0	1.23
BLA	intron excision ratio	0	0	1.17
BLA	mRNA stability	0	0	1.24
Brain	alternative polyA	0	0	1.13
Brain	alternative TSS	0	0	1.26
Brain	gene expression	1	0	1.23
Brain	isoform ratio	0	0	1.24
Brain	intron excision ratio	0	0	1.17
Brain	mRNA stability	0	0	1.25
Eye	alternative polyA	0	0	1.22
Eye	alternative TSS	0	0	1.29
Eye	gene expression	0	0	1.22
Eye	isoform ratio	0	0	1.33
Eye	intron excision ratio	0	0	1.27
Eye	mRNA stability	0	0	1.28
IC	alternative polyA	0	0	1.21
IC	alternative TSS	0	0	1.24
IC	gene expression	0	0	1.25
IC	isoform ratio	0	0	1.2
IC	intron excision ratio	0	0	1.18
IC	mRNA stability	0	0	1.27
IL	alternative polyA	0	0	1.13
IL	alternative TSS	0	0	1.06
IL	gene expression	0	0	1.22
IL	isoform ratio	0	0	1.2
IL	intron excision ratio	0	0	1.16
IL	mRNA stability	0	0	1.19
LHb	alternative polyA	0	0	1.18
LHb	alternative TSS	0	0	1.22
LHb	gene expression	0	0	1.2
LHb	isoform ratio	0	0	1.16
LHb	intron excision ratio	0	0	1.11
LHb	mRNA stability	0	0	1.21
Liver	alternative polyA	0	0	1.17
Liver	alternative TSS	0	0	1.16
Liver	gene expression	0	0	1.2
Liver	isoform ratio	0	0	1.2
Liver	intron excision ratio	0	0	1.16
Liver	mRNA stability	0	0	1.25
NAcc	alternative polyA	2	0.1	206.97
NAcc	alternative TSS	0	0	1.25
NAcc	gene expression	0	0	1.23
NAcc	isoform ratio	0	0	1.2
NAcc	intron excision ratio	2	0	1.19
NAcc	mRNA stability	0	0	1.29
OFC	alternative polyA	0	0	1.19
OFC	alternative TSS	0	0	1.16
OFC	gene expression	0	0	1.26
OFC	isoform ratio	0	0	1.25
OFC	intron excision ratio	0	0	1.11
OFC	mRNA stability	0	0	1.19
PL	alternative polyA	0	0	1.18
PL	alternative TSS	0	0	1.2
PL	gene expression	1	0	1.23
PL	isoform ratio	0	0	1.23
PL	intron excision ratio	0	0	1.17
PL	mRNA stability	0	0	1.3
pVTA	alternative polyA	0	0	1.19
pVTA	alternative TSS	0	0	1.36
pVTA	gene expression	1	0	1.28
pVTA	isoform ratio	0	0	1.29
pVTA	intron excision ratio	0	0	1.21
pVTA	mRNA stability	0	0	1.27
RMTg	alternative polyA	0	0	1.26
RMTg	alternative TSS	0	0	1.18
RMTg	gene expression	0	0	1.23
RMTg	isoform ratio	0	0	1.31
RMTg	intron excision ratio	0	0	1.2
RMTg	mRNA stability	0	0	1.28